Volition is a multi-national epigenetics company developing simple, easy-to-use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including cancer and those associated with NETosis such as sepsis and COVID-19.
Our tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Volition's research and development activities are centered in Belgium, with an innovation laboratory in California and additional offices in USA, London, and Singapore.
Volition 是一家跨國表觀遺傳學公司，開發簡單、易於使用且具成本效益的血液測試，以幫助診斷和監測包括癌症和與 NETosis 相關如敗血症和 COVID-19的疾病；應用 Nucleosomics™ 科學來識別和測量血液或其他體液中的核小體以明確診斷疾病。 Volition 主要專注於人類診斷和監測，但也有一家子公司專注於動物診斷和監測。Volition 研發活動以比利時為中心，在加利福尼亞州設有創新實驗室，並在美國、倫敦和新加坡設有辦事處。